Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -56.31% is 57% below its 5-year average of -35.79%, near the low end of its 5-year range (-56.31%–-21.78%).
17.53% below its 12-month average of -47.91%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -15.22%.
RETURN ON ASSETS (ROA)
-56.31%
RETURN ON ASSETS (ROA) AVG TTM
-47.91%
RETURN ON ASSETS (ROA) AVG 3Y
-41.18%
RETURN ON ASSETS (ROA) AVG 5Y
-35.79%
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
-17.53%
CURRENT VS 3Y AVG
-36.73%
CURRENT VS 5Y AVG
-57.33%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-30.18%
median of 674 covered companies
CURRENT VS SECTOR MEDIAN
-86.55%
vs the sector median at left
CVRx, Inc.
Market Cap
$43.25M
Return on Assets (ROA)
-56.31%
TTM Avg
-47.91%
3Y Avg
-41.18%
5Y Avg
-35.79%
Market Cap
$44.18M
Return on Assets (ROA)
-128.10%
TTM Avg
-35.87%
3Y Avg
-35.25%
5Y Avg
-29.40%
Market Cap
$44.31M
Return on Assets (ROA)
70.17%
TTM Avg
-36.93%
3Y Avg
-46.92%
5Y Avg
-57.84%
Market Cap
$41.92M
Return on Assets (ROA)
-5.70%
TTM Avg
-13.47%
3Y Avg
-29.01%
5Y Avg
-32.57%
Market Cap
$44.50M
Return on Assets (ROA)
-57.95%
TTM Avg
4.78%
3Y Avg
-64.05%
5Y Avg
-66.64%
Market Cap
$41.74M
Return on Assets (ROA)
-40.69%
TTM Avg
-38.43%
3Y Avg
-19.21%
5Y Avg
-15.37%
Market Cap
$45.24M
Return on Assets (ROA)
-143.30%
TTM Avg
-71.59%
3Y Avg
-49.53%
5Y Avg
-40.25%
Market Cap
$40.28M
Return on Assets (ROA)
-53.81%
TTM Avg
-31.90%
3Y Avg
-23.26%
5Y Avg
-21.62%
Market Cap
$39.90M
Return on Assets (ROA)
11.01%
TTM Avg
4.71%
3Y Avg
-17.75%
5Y Avg
-20.00%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CVRx, Inc. (CVRX) | $43.25M | -56.31% | -47.91% | -41.18% | -35.79% |
| Nano-X Imaging Ltd. (NNOX)vs › | $44.18M | -128.10% | -35.87% | -35.25% | -29.40% |
| DarioHealth Corp. (DRIO)vs › | $44.31M | 70.17% | -36.93% | -46.92% | -57.84% |
| Precipio, Inc. (PRPO)vs › | $41.92M | -5.70% | -13.47% | -29.01% | -32.57% |
| BioStem Technologies, Inc. (BSEM)vs › | $44.50M | -57.95% | 4.78% | -64.05% | -66.64% |
| Filana Therapeutics, Inc. (FLNA)vs › | $41.74M | -40.69% | -38.43% | -19.21% | -15.37% |
| Werewolf Therapeutics, Inc. (HOWL)vs › | $45.24M | -143.30% | -71.59% | -49.53% | -40.25% |
| Metagenomi, Inc. Common Stock (MGX)vs › | $40.28M | -53.81% | -31.90% | -23.26% | -21.62% |
| Nephros, Inc. (NEPH)vs › | $39.90M | 11.01% | 4.71% | -17.75% | -20.00% |
| Harvard Bioscience, Inc. (HBIO)vs › | $38.97M | -13.65% | -40.30% | -22.41% | -15.81% |
ROA
-56.3%
ROE
-260.4%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -50.87% |
| 2024-12-31 | -44.95% |
| 2023-12-31 | -35.75% |
| 2022-12-31 | -33.16% |
| 2021-12-31 | -28.24% |
| 2020-12-31 | -21.78% |
| 2019-12-31 | -50.27% |
